AAV GENE THERAPY SEQUENCING
Adeno-associated virus (AAV) gene therapy sequencing enables you to verify the quality and integrity of packaged AAV vectors, including inverted terminal repeat (ITR) regions, measure AAV expression after infection, monitor host response, and much more.
Whether you need to sequence a packaged AAV product, AAV plasmid, or interested in post-infection solutions, we offer custom, in-depth AAV gene therapy sequencing for your complex AAV applications. Our solutions combine next generation sequencing (NGS) using the latest technologies, such as PacBio® long-read (>10kb) or Illumina® short-read sequencing, with our proprietary QC process to provide you with reliable, accurate results and streamline your AAV gene therapy research.